Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006339
Status:
WITHDRAWN
Last Update Posted:
2021-11-01
First Post:
2000-10-04
Brief Title:
Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HIV Infections |
Keywords:
| Name | View |
|---|---|
| Prospective Studies | View |
| HIV-1 | View |
| Didanosine | View |
| Drug Therapy Combination | View |
| Stavudine | View |
| HIV Protease Inhibitors | View |
| Hydroxyurea | View |
| Ritonavir | View |
| Indinavir | View |
| Reverse Transcriptase Inhibitors | View |
| Anti-HIV Agents | View |
| Viral Load | View |
| Reverse Transcriptase Polymerase Chain Reaction | View |